At Artevet Therapeutics, we combine cutting-edge manufacturing, rigorous quality control and scientific precision to produce veterinary therapeutic and nutritional formulations trusted worldwide. Driven by innovation, we develop next-generation solutions that redefine animal health and care. With a global footprint and deep local expertise, we deliver consistent quality, reliability and value to our partners across the world.
About Artevet Therapeutics
Our Mission
To be the premier manufacturing facility for veterinary drugs globally, providing top-quality branded products and exceptional contract manufacturing solutions, while adhering to sustainable manufacturing practices and the highest regulatory compliance standards.
Our Vision
To become one of Asia’s leading and only USFDA-compliant veterinary formulation facilities, adhering to all local and international regulatory standards. We aim to facilitate global market access for Artevet and our partners, ensuring the highest quality and safety in veterinary drugs.
Our Journey of Innovation & Growth
Our timeline reflects the key achievements, innovations, and expansions that shaped our journey.
Each milestone marks a step forward in our commitment to excellence and global standards.
- 2023
- 2024
- 2025
Artevett Therapeutics was incorporated, marking the beginning of our mission to advance animal health.
First batch of production commenced, bringing our innovative veterinary solutions to life.
Introduction of Companion range products, expanding our portfolio to better serve pets and companion animals.
WHO & GMP certifications achieved, ensuring our products meet the highest global quality standards.
APVMA registration completed, strengthening our international presence and regulatory compliance.
Founder's Message
At Artevet Therapeutics, we support our community by hiring locally, employing over 200 people per shift and promoting diversity through the inclusion of talented women. Guided by FDA-approved experts and dedicated managers, we uphold top standards in production and quality control to advance animal health globally. Our facility in India was chosen for its strategic location, skilled workforce and access to key suppliers, enabling efficient, high-quality output.
We believe Artevet Therapeutics will become a driving force within our Artevet group, while supplying world-class veterinary formulations under the most stringent regulatory frameworks, benefitting our partners and animals worldwide.
Aniket Parikh
Founder & CEO
